RT-qPCR validated differential expression of WDR72, ANLN, and SLC16A12 in normal renal versus ccRCC tumor tissues, supporting their potential as diagnostic and therapeutic biomarkers. This evidence concerns the gene ANLN and nonpapillary renal cell carcinoma.